Back to results
US 10,882,830 B2Granted
Crystal form of ozanimod hydrochloride and processes for preparation therefor
AssigneeReceptos, Inc.
InventorsMinhua Chen, Yanfeng Zhang, Xiaoting Zhai, Kaiqiang Yan, Chaohui Yang, Xiaoyu Zhang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to crystalline form CS3 of ozanimod hydrochloride which can be used for treating autoimmune diseases, particularly used for preparing drugs for treating multiple sclerosis and ulcerative colitis and preparation method thereof.
Claims12
A crystalline form CS3 of ozanimod hydrochloride, wherein the X-ray powder diffraction pattern shows characteristic peaks at 2 theta values of 19.6°±0.2°, 24.9°±0.2° and 5.8°±0.2° using CuKα radiation.
Dependencies are inferred from the claim text.